. "B8. Use of Antiprogestins in the Management of Endometriosis and Leiomyoma." Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press, 1993.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda
endometrium during the menstrual cycle and the effect of medical therapy. Fertility and Sterility 51:409–414, 1989.
Liu, J.H., and Yen, S.S.C. Induction of midcycle gonadotropin surge by ovarian steroid in women: A critical evaluation. Journal of Clinical Endocrinology and Metabolism 57:797–802, 1983.
Liu, J.H., Garzo, G., Morris, S., et al. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU 486. Journal of Clinical Endocrinology and Metabolism 65:1135–1140, 1987.
Lumsden, M.A., West, C.P., Hawkins, R.A., et al. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630). Journal of Endocrinology 121:389–396, 1989.
Luukkainen, T., Heikinheimo, O., Haukkamaa, M., et al. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Fertility and Sterility 49:961–963, 1988.
Matta, W.H., Shaw, R.W., Hesp, R., et al. Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women. Clinical Endocrinology 29:45–51, 1988a.
Matta, W.H., Stabile, I., Shaw, R.W., et al. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist buserelin. Fertility and Sterility 49:1083–1085, 1988b.
Metzger, D.A., Szpak, C.A., and Haney, A.F. Histologic features associated with hormonal responsiveness of ectopic endometrium. Fertility and Sterility 59:83, 1993.
Neulen, J., Williams, R.F., Hodgen, G.D., et al. RU 486 (mifepristone): Induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. Journal of Clinical Endocrinology and Metabolism 71:1074–1075, 1990.
Perl, V., Marquez, J., Schally, A.V., et al. Treatment of leiomyomata uteri with D-Trp6 luteinizing hormone-releasing hormone. Fertility and Sterility 48:383–389, 1987.
Rein, M.S., Friedman, A.J., Stuart, J.M., et al. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertility and Sterility 53:1018, 1990.
Roseff, S.R., Kettel, L.M., Rivier, J., et al. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women. Fertility and Sterility 54:805, 1990.
Rummon, I.S., Radwanska, E., Ali, A., et al. Bone mineral density in women with endometriosis and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol. Fertility and Sterility 49:792–796, 1988.
Schaison, G., George M., Lestrat, N., et al. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. Journal of Clinical Endocrinology and Metabolism 61:484–489, 1985.
Schlaff, W.D., Zerhouni, E.A., Huth, J.A., et al. A placebo-controlled trial of a depot GnRH analogue (leuprolide) in the treatment of uterine leiomyomata. Obstetrics and Gynecology 74:857–862, 1989.
Shaw, R.W. Treatment of Endometriosis. Lancet 340:1267, 1992.
Weigel, N.L., Beck, C.A., Estes, P.A., et al. Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Molecular Endocrinology 6:1585–1597, 1992.
West, C.P., Lunsden, M.A., Lawson, S., et al. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): A LHRH agonist administered as a monthly subcutaneous depot. Fertility and Sterility 48:45–51, 1987.
Wolf, J.P., Hsiu, J.F., Anderson, T.L., et al. Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and proliferative action of estradiol on endometrium in castrate monkeys. Fertility and Sterility 52:1055–1060, 1989.